573 Results (Page 12 of 23)
France Markets Research Reports
France Skin Antiseptic Products Market Analysis
This report presents a strategic analysis of the France Skin Antiseptic Products Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the French skin Antiseptic Products Market, offering unmatched value, accuracy, and expert insights.
France Radiotherapy Market Analysis
By 2030, it is anticipated that the France Radiotherapy Market will reach a value of $281 Mn from $190 Mn in 2022, growing at a CAGR of 5% during 2022-2030. The Radiotherapy Therapeutics Market in France is dominated by a few domestic players such as Orfit Industries, Median Technologies, and Dosisoft. The radiotherapy market in France is segmented into different types, technologies, procedures, applications, and end-users. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for French radiotherapy is increasing on account of the rise in cancer cases in the country.
France Medical Devices Market Analysis
This report presents a strategic analysis of the France Medical Devices Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the France Medical Devices Market, offering unmatched value, accuracy, and expert insights.
France Liver Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the France Liver Cancer Therapeutics market will reach a value of $275.3 Mn from $80.6 Mn in 2022, growing at a CAGR of 16.6% during 2022-30. Liver Cancer Therapeutics in France is dominated by a few domestic pharmaceutical companies such as Sanofi, Servier, and Transgene. The Liver Cancer Therapeutics market in France is segmented into different types of cancer and different therapy types. Some of the major factors affecting the France Liver Cancer Therapeutics market are the growing prevalence of liver cancer and the high cost and side effects related to certain liver cancer therapies.
France ENT Devices Market Analysis
France's ENT Devices Market is projected to grow from $640 Mn in 2022 to $920 Mn by 2030, registering a CAGR of 4.8% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the French ENT devices market include Olympus Medical Systems, L'AC International, and Myring SAS.
France Diabetes Therapeutics Market Analysis
France's diabetes therapeutics market is expected to grow from $3.95 Bn in 2022 to $7.71 Bn in 2030 with a CAGR of 8.7% for the forecasted year 2022-30. The growing prevalence of diabetes as a result of increasing sedentary lifestyle adoption in France is responsible for the growth of the market. The France diabetes therapeutics market is segmented by type, application, drug, route of administration, and distribution channel. Elaiapharm, AdhexPharma, and Novo Nordisk are the major players in the France diabetes therapeutics market.
France Coronary Stents Market Analysis
France's Coronary Stents Market is expected to witness growth from $311 Mn in 2022 to $417 Mn in 2030 with a CAGR of 3.75% for the forecasted year 2022-30. In France, stent installation is one of many minimally invasive procedures that are becoming more popular. The use of stents is becoming more popular because patients frequently prefer them to more invasive procedures like bypass surgery. The market is segmented by type, mode of delivery, materials, and end user. Some key players in this market include Stentys, Delacroix-Chevalier, Marquat, B. Braun, Abbott Laboratories, Biotronik, Medtronic, GE Healthcare, Boston Scientific, and Philips Healthcare.
France Contraceptive Devices Market Analysis
France's Contraceptive Devices Market is expected to witness growth from $355 Mn in 2022 to $610 Mn in 2030 with a CAGR of 7.00% for the forecasted year 2022-30. To encourage family planning and contraception, the French government has put regulations into place, such as offering free contraception to women under the age of 25. This support is boosting the demand for contraceptive methods and opening up businesses for manufacturers. The market is segmented by type and by gender. Some key players in this market include Laboratoire CCD, HRA Pharma, Mylan Laboratories, Church & Dwight, CooperSurgical, Pfizer, Pregna International, and Teva Pharmaceutical.
France Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market Analysis
France's Chronic Obstructive Pulmonary Disease (COPD) therapeutics market was valued at $502 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.1% from 2022 to 2030 and will reach $806 Mn in 2030. One of the main reasons propelling the growth of this market is the increased prevalence rate of the aging population. The market is segmented by Drug class and By distribution channel. Some key players in this market are Salt Med, Adamis Pharmaceuticals Corporation, Almirall, Astellas Pharma, American Hospital of Paris, Boehringer Ingelheim Pharmaceuticals, Novartis, Pfizer, and others.
France Cancer Immunotherapy Market Analysis
France's cancer immunotherapy market is expected to witness growth from $3.09 Bn in 2022 to $4.96 Bn in 2030 with a CAGR of 6.1% for the forecasted year 2022-30. The increase in the aging population and the availability of newer and more potential immunotherapies for the treatment of cancer in France are the major market drivers. The France cancer immunotherapy market is segmented by type, application, and end user. Biomunex Pharmaceuticals, Transgene, and AstraZeneca are the major players in the France cancer immunotherapy market.
France Antiviral Drugs Market Analysis
This report presents a strategic analysis of the France Antiviral Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the French antiviral Drugs Market, offering unmatched value, accuracy, and expert insights.
France Advanced Therapy Medicinal Products (ATMPs) Market Analysis
This report presents a strategic analysis of the France Advanced Therapy Medicinal Products (ATMPs) Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges, and future outlook. This is one of the most comprehensive reports about the French advanced Therapy Medicinal Products (ATMPs) Market, offering unmatched value, accuracy, and expert insights.
France ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market Analysis
France's ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market is projected to grow from $0.813 Bn in 2022 to $1.046 Bn by 2030, registering a CAGR of 3.20% during the forecast period of 2022-30. The French government plays a significant role in the market through its reimbursement policies and regulations, which can affect the pricing and availability of drugs. Some of the major players in the French ADHD drugs market include Shire (now part of Takeda), Novartis, and Johnson & Johnson.
France 3D Imaging Market Analysis
France's 3D imaging market is projected to grow from $0.84 Bn in 2022 to $2.65 Bn by 2030, registering a CAGR of 15.5% during the forecast period of 2022-30. The market will be driven by improved patient outcomes owing to technological advancements and decreased healthcare expenses. The market is segmented by product, application, end-user & portability. Some major players include GE Healthcare, Siemens Healthineers & EOS Imaging.
France Over The Counter (OTC) Pharmaceuticals Market Analysis
France's over-the-counter (OTC) pharmaceuticals market size was valued at $3781.3 Mn in 2022 and is estimated to expand at a CAGR of 4.54% from 2022 to 2030 and will reach $5393.8 Mn in 2030. OTC are non-prescription medications and are a vital component of the healthcare system, offering consumers accessible solutions for a wide range of common health issues. The market is segmented by product type and distribution channel. The key market players are Johnson and Johnson Services Inc (USA), Bayer AG (Germany), Novartis AG (Switzerland) and others.
France Alzheimer’s Disease Drugs Market Analysis
The France Alzheimer’s Disease Drugs market was valued at $424 Mn in 2022 and is estimated to expand at a CAGR of 7.42% from 2022-30 and will reach $752 Mn in 2030. One of the main reasons propelling the growth of this market is government support, and the aging population. The market is segmented by drug classes and by Distribution Channels. Some key players in this market are Alexion Pharma, Takeda Pharmaceuticals, Biogen, Daiichi Sankyo Company, Eisai Co., Eli Lilly and Company, Johnson and Johnson, H. Lundbeck A/S, F. Hoffmann-La Roche AG, Merck & Co., Novartis AG, Ono Pharmaceutical Co., Pfizer, and Teva Pharmaceutical among others.
France Anemia Drugs Market Analysis
France's Anemia drugs market was valued at 439 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 7.9% from 2022 to 2030 and will reach $807 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies and the increase in chronic diseases. The market is segmented by type, drug, and distribution channel. Some key players in this market are Amgen, Aspen, AstraZeneca, Bristol Myers Squibb, Chiesi Farmaceutici, Curium, and Daiichi Sankyo Co.
France Alexipharmic Drugs Market Analysis
France's Alexipharmic drugs market size was valued at $xx Bn in 2022 and is estimated to expand at a CAGR of 3.70% from 2022-30 and will reach $xx Bn in 2030. The market is segmented by product type, indication, route of administration, end-user, and distribution channel. The France Alexipharmic Drugs market will grow because of growing people are also becoming more aware of the dangers of poisoning and how crucial it is to have quick access to antidotes in case of an emergency. The key market players are Sanofi (FRA), Seqens (FRA), Adocia (FRA), Laboratoires Chemineau (FRA), and others.
France Biosimilars Market Analysis
France's biosimilars market size was valued at $0.5 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 21.4% from 2022 to 2030 and will reach $2.4 Bn in 2030. The market is segmented by product type and indication type. The France Biosimilars market will grow with the increased incidence of chronic illnesses, rising healthcare expenses, and the demand for affordable biologic medicine substitutes. The key market players are Sanofi, Pfizer, Biogen, Mylan, Amgen, and others.
France Rheumatology Drugs Market Analysis
France's Rheumatology Drugs Market is projected to grow from $1.679 Bn in 2022 to $1.936 Bn by 2030, registering a CAGR of 1.80% during the forecast period of 2022-30. Biologics, such as tumor necrosis factor (TNF) inhibitors and interleukin (IL) inhibitors, are among the most commonly used treatments for rheumatic diseases in France. These drugs are considered to be more effective than traditional small-molecule drugs and are becoming increasingly popular. In terms of market players, France is home to several pharmaceutical companies that produce rheumatology drugs, including Sanofi, Roche, and Pfizer
France Physiotherapy Market Analysis
France's physiotherapy market size was valued at $1.46 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 4.85% from 2022 to 2030 and will reach $2.13Bn in 2030. France's physiotherapy market is expected to grow due to, an aging population, an increase in chronic diseases, and a growing focus on preventative care. The market is segmented by Product Type, Application Type, and End User. The major players in the France physiotherapy market are EMS Physio, DJO Global, Inc. Ormed, Medifa, Physiosupplies, Medequip, and others.
France Home Healthcare Market Analysis
France's home healthcare market was valued at $9.97 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.93% from 2022-30 and will reach $17.05 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies and the increased prevalence of chronic diseases. The market is segmented by equipment outlook and by services. Some key players in this market are ADOMA, Korian, Orpea, and Qualitel.
France Dialysis Market Analysis
France's Dialysis Market is projected to grow from $3.196 Bn in 2022 to $4.905 Bn by 2030, registering a CAGR of 5.5% during the forecast period of 2022-30. France has a well-developed healthcare infrastructure, with a large number of public hospitals and dialysis centers. This is helping to ensure that patients have access to high-quality dialysis services. Fresenius Medical Care is a global leader in the dialysis market and has a significant presence in France. The company operates a network of dialysis clinics and provides a wide range of dialysis products and services.
France Clinical Diagnostics Market Analysis
France's clinical diagnostic market was valued at $1.9 Bn in 2022 and is estimated to expand at a CAGR of 5% from 2022-30 and will reach $2.8 Bn in 2030. One of the main reasons propelling the growth of this market is an increase in chronic disease and advancement in technology. The market is segmented by type, drug, and distribution channel. Some key players in this market are Abbott, BD, bioMérieux SA, Bio-Rad Laboratories, Danaher Corporation, Siemens AG, Hologic, Qiagen NV, Quest Diagnostics, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Sysmex, Diaxonhit, Eurofins Scientific, Genomic Vision, Stago, and others.
France Acne Therapeutics Market Analysis
France's acne therapeutics market is expected to witness growth from $276 Mn in 2022 to $430 Mn in 2030 with a CAGR of 5.7% for the forecast year 2022-2030. The rising demand for acne medications for the acne increasing incidence of acne in France is the major market driver for the market. The France acne therapeutics market is segmented by treatment, route of administration, age group, and distribution channel. Some of the key competitors in the market are Pierre Fabre, Ceva Santé Animale, and Teva Pharmaceuticals.
